Related Experiment Videos
Strengths and weaknesses of drug trials without controls
Journal of Cardiovascular Pharmacology
|December 5, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Arterial compliance may be reduced by ingestion of red wine.
Journal of human hypertension·2015
Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).
Journal of human hypertension·2011
Self management and patient understanding of diabetes in the older person.
Diabetic medicine : a journal of the British Diabetic Association·2010
The prevalence of Type 2 diabetes and its associated health problems in a community-dwelling elderly population.
Diabetic medicine : a journal of the British Diabetic Association·2009
Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects.
Journal of human hypertension·2008
Statins In Dialysis-Dependent End-Stage Renal Disease: Reconciling Discordant Evidence Through GRADE-Informed Appraisal and Evidence-to-Decision Framework.
Journal of cardiovascular pharmacology·2026
Triple Antithrombotic Therapy for the Prevention of Left Ventricular Thrombus Following Anterior ST-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
Journal of cardiovascular pharmacology·2026
Eplerenone Revisited: A Balanced Reappraisal of Its Role in Hypertension, Heart Failure, and Cardiorenal Disease.
Journal of cardiovascular pharmacology·2026
Targeting IL-1 in SLE-Associated Recurrent Pericarditis: A Case Series and Review of Mechanistic Rationale.
Journal of cardiovascular pharmacology·2026
Cardiovascular and Thromboembolic Risk With Upadacitinib in Spondyloarthritis and Inflammatory Bowel Disease: A Meta-Analysis of Randomized Controlled Trials.
Journal of cardiovascular pharmacology·2026
Empagliflozin Reduces Post-Myocardial Infarction Inflammation via BDH1/β-Hydroxybutyrate-Mediated NF-κB Modulation in Macrophages and the Heart.
Journal of cardiovascular pharmacology·2026